Duke

Running trials

• Recruiting

  The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

  NCT07612878· Source

• Recruiting

  Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD

  NCT06233110· Phase 1· Source

• Recruiting

  Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction

  NCT06733012· Source

• Recruiting

  Ferric Citrate and Chronic Kidney Disease in Children

  NCT04741646· Phase 2· Source

• Recruiting

  Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

  NCT04575935· Phase 3· Source

• Active, not recruiting

  Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

  NCT04273945· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• COPD1 recruiting
• Heart failure1 recruiting
• Ovarian cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

  NCT05974150· Source

• Completed

  The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study

  NCT05294705· Source

• Completed

  Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

  NCT04069312· Phase 3· Source